OpenAI Closes $122 Billion Funding Round at $852 Billion Valuation

351 reads

Read the original article →

OpenAI Closes $122 Billion Funding Round at $852 Billion Valuation

OpenAI announced on March 31, 2026, the close of a $122 billion funding round, the largest private technology financing in history. The round values OpenAI at $852 billion post-money.

Investors

The round includes Amazon, NVIDIA, SoftBank, and Microsoft as strategic investors. OpenAI also raised $3 billion from retail investors, an unusual move for a company that has not yet gone public.

Scale of Operations

ChatGPT now has over 900 million weekly active users and more than 50 million paying subscribers. OpenAI generates $2 billion in monthly revenue. Enterprise customers now account for over 40% of that revenue and are on track to reach parity with consumer revenue by end of 2026.

What the Money Will Fund

OpenAI plans to use the capital for expanded compute infrastructure, multi-cloud and chip partnerships, and development of a unified AI superapp combining ChatGPT, Codex, and agentic capabilities. The company is also investing in global AI infrastructure to support growing demand.

IPO Expectations

The funding round has fueled speculation about an OpenAI IPO. At $852 billion, the company would be among the most valuable public listings in history if it goes public at or above this valuation.

Why It Matters

The round signals continued investor confidence in AI despite growing questions about profitability across the industry. With $122 billion in fresh capital, OpenAI has more resources than most publicly traded technology companies, giving it significant runway to pursue its product and infrastructure ambitions.

Related articles

  • Isomorphic Labs Drug Design Engine Doubles AlphaFold 3 Accuracy, Heads to Clinical Trials

    Isomorphic Labs, the drug discovery spinoff from Google DeepMind, released its Drug Design Engine (IsoDDE), which doubles AlphaFold 3's accuracy in predicting protein-ligand structures. The first AI-designed cancer drug is entering Phase 1 clinical trials. Isomorphic has $3 billion in potential milestone payments from partnerships with Eli Lilly and Novartis.

  • Alibaba Releases Qwen 3.5 Omni, a Multimodal Model That Codes From Video and Voice

    Alibaba's Qwen team released Qwen 3.5 Omni, a native multimodal model that processes text, images, audio, and video in a single pipeline. It supports 256k context, over 10 hours of audio, and 400 seconds of 720p video. The team reported an emergent capability they call Audio-Visual Vibe Coding, where the model writes functional code from watching a video and listening to spoken instructions.

  • India AI Impact Summit Concludes With 91 Countries Adopting the New Delhi Declaration

    The India AI Impact Summit in New Delhi drew over 20 heads of state and tech leaders including Sundar Pichai, Sam Altman, and Demis Hassabis. 92 countries and international organizations adopted the AI Impact Summit Declaration. India's PM Modi presented the M.A.N.A.V. Vision for AI, a framework centered on moral systems, accountable governance, national sovereignty, accessibility, and validity.

  • AI Scientist v2 Produces First AI-Generated Paper Accepted at Peer-Reviewed Workshop

    Sakana AI released AI Scientist v2, an open-source system that autonomously proposes hypotheses, runs experiments, analyzes data, and writes scientific papers. For the first time, an entirely AI-generated manuscript passed peer review at a recognized machine learning workshop. The system uses agentic tree search and a vision-language model feedback loop.

References

Discussion

  • Loading…

← Back to News